Moderna
MRNA
#232
Rank
NZ$181.27 B
Marketcap
NZ$448.01
Share price
-6.75%
Change (1 day)
918.19%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): NZ-$13.90

According to Moderna 's latest financial reports the company's current EPS (TTM) is NZ-$14.27. In 2025 the company made an earnings per share (EPS) of NZ-$12.98 an increase over its 2024 EPS that were of NZ-$16.58.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$13.907.06%
2025NZ-$12.98-21.66%
2024NZ-$16.58-25.04%
2023NZ-$22.11-158.62%
2022NZ$37.72-30.25%
2021NZ$54.08-1660.82%
2020NZ-$3.4725.32%
2019NZ-$2.7636.87%
2018NZ-$2.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.94-183.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.38-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$1.77-112.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ-$1.30-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ-$3.63-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.38-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$5.95-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA